MTOR and cancer: For instance, disrupting crucial signaling pathways such as PI3K/AKT/mTOR or MAPK could, inadvertently, induce compensatory mechanisms within the cancer cells, potentially leading to more aggressive tumor behavior rather than promoting cell death [110].